Skip to main content
Caplight Logo









Vetbiolix

Vetbiolix

Private
LoosHealthcare & Life Scienceshttps://www.vetbiolix.com/

Last Round

Series A

Dec 2, 2024

Total Funding Raised

$6.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Vetbiolix is a biotechnology company that develops innovative prescription medicines and care products for the treatment and prevention of diseases affecting pets, focusing on periodontitis, osteoarthritis, and gut motility disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

veterinary biotechnologysmall molecule therapeuticsdrug repurposingveterinary drug developmentpet medicineout-licensingcompanion animal healthclinical-stage biotechveterinary pharmaceuticalsone healthdrug licensingpet pharmaanimal health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vetbiolix Comparables

Compare Vetbiolix with similar companies based on industry and business-model similarity.

Vetbiolix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Okava Pharmaceuticals
84%
Vetigenics Inc.
79%
Vetbiobank
78%

Vetbiolix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 2, 2024
SeedSep 12, 2022

Vetbiolix Investors

Notable investors and investment history

Vetbiolix investors
InvestorRounds
TudigoSeries A
EurasantéSeed
BpifranceSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2026

    Monthly visitors increased 219% MoM, reaching 1.7K.

  • May 16, 2026

    Monthly visitors grew 124% MoM, from 241 to 541.

Vetbiolix Filings

Explore SEC and related filing metadata, where available.

Vetbiolix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vetbiolix's valuation, stock price, and market status.

Is Vetbiolix a public or private company?

Vetbiolix is a private company.

What is the current stock price of Vetbiolix?

Vetbiolix is a private company with no public stock price. No recent secondary market data is available.

How much is Vetbiolix worth (valuation)?

Valuation information for Vetbiolix is not publicly available.

Can I buy Vetbiolix stock?

Vetbiolix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vetbiolix's last funding round?

Vetbiolix's most recent funding round was Series A on December 3, 2024.

Who are the main investors in Vetbiolix?

Investor information for Vetbiolix is not publicly disclosed.

Will Vetbiolix IPO soon?

No public IPO plans have been announced for Vetbiolix.

How can I track Vetbiolix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vetbiolix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLoos
Employee Range5
Year Founded2018
Last FundingDec 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?